← Back to Clinical Trials
Recruiting NCT07455656

NCT07455656 Assessment of the Locally Administrated Vitamin D3 and Corticision Efficacy on Orthodontic Canine Retraction

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07455656
Status Recruiting
Phase
Sponsor Al-Azhar University
Condition Malocclusions
Study Type INTERVENTIONAL
Enrollment 16 participants
Start Date 2025-08-01
Primary Completion 2026-08-01

Eligibility & Interventions

Sex All sexes
Min Age 13 Years
Max Age 20 Years
Study Type INTERVENTIONAL
Interventions
patients will receive local application of vitamin D3 combined with corticision

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 16 participants in total. It began in 2025-08-01 with a primary completion date of 2026-08-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

To study the effect vitamin D effect on orthodontic tooth movement when used in combination with coticision technique, independent t test or an equivalent non-parametric test will be used for comparison. According to a previous study by (S. T. Varughese, et al. (2019) , "Effect of vitamin D on canine distalization and alveolar bone density using multi-slice spiral CT: a randomized controlled trial

Eligibility Criteria

Inclusion criteria: 1. Orthodontic patients referred for therapeutic extraction of bilateral maxillary first premolars (Angle Class II division 1 cases, with crowding and bimaxillary protrusion). 2. Fully erupted permanent teeth (except third molar). 3. Age 13-20 patients. 4. No previous orthodontic treatment. 5. Good oral and general health. 6. No systemic disease or regular medication that could interfere with and/or affect orthodontic teeth movement. Exclusion criteria: 1. Patients with impacted canines. 2. Patients with severe crowding. 3. Patients with untreated decay or any endodontic lesions. 4. Patients with thyroid, parathyroid, or renal and liver disease.

Contact & Investigator

Central Contact

Mahmoud Elsaid Elsayed E Mahmoud Elsaid, BDS

✉ mahmoud_elsaid@azhar.edu.eg

📞 +201003221008

Principal Investigator

Dr. Ramadan Yusuf Abu-Shahba Y Dr. Ramadan Yusuf Abu-Shahba, PhD

STUDY DIRECTOR

rmadanyusf@azhar.edu.eg

Frequently Asked Questions

Who can join the NCT07455656 clinical trial?

This trial is open to participants of all sexes, aged 13 Years or older, up to 20 Years, studying Malocclusions. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07455656 currently recruiting?

Yes, NCT07455656 is actively recruiting participants. Contact the research team at mahmoud_elsaid@azhar.edu.eg for enrollment information.

Where is the NCT07455656 trial being conducted?

This trial is being conducted at Cairo, Egypt.

Who is sponsoring the NCT07455656 clinical trial?

NCT07455656 is sponsored by Al-Azhar University. The principal investigator is Dr. Ramadan Yusuf Abu-Shahba Y Dr. Ramadan Yusuf Abu-Shahba, PhD at rmadanyusf@azhar.edu.eg. The trial plans to enroll 16 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology